ECALLANTIDE

CHEBI:CHEBI_755505

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
884702
product_type
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20241231
dosage_form
INJECTION, SOLUTION
route
SUBCUTANEOUS
active_ingredient_strength
10 mg/mL
marketing_category
DRUG FOR FURTHER PROCESSING
pharm_class_moa
Kallikrein Inhibitors [MoA]
pharm_class
Plasma Kallikrein Inhibitor [EPC]
pharm_class_epc
Plasma Kallikrein Inhibitor [EPC]
labeler_name
FUJIFILM Diosynth Biotechnologies UK Ltd.
manufacturer_name
Takeda Pharmaceuticals America, Inc.
marketing_start_date
20100202
package_marketing_start_date
02-FEB-10
nui
N0000184151
generic_name
Ecallantide
active_ingredient_name
ECALLANTIDE
product_ndc
47783-101
spl_id
18790228-a777-4dc5-a566-aafa7cdeff36
package_ndc
47783-101-01
package_description
3 VIAL, GLASS in 1 CARTON (47783-101-01) / 1 mL in 1 VIAL, GLASS
brand_name
Kalbitor
brand_name_base
Kalbitor
application_number
BLA125277
unii
5Q6TZN2HNM
spl_set_id
f56aec67-c662-477c-b866-bfc23e8809cf
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class